Rhumbline Advisers »

Terns Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $374k 58k 6.49
2023-09-30 $297k 59k 5.03
2023-06-30 $507k 58k 8.75